Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Shri Dinesh Mills Ltd. Share Price

₹ 316.55 -8.20 (-2.52%)

Apr 16 2025 09:36 AM Textiles NSE: SHRIDINE

Shri Dinesh Mills Ltd. Share Price Update

As of the latest trading session, Shri Dinesh Mills Ltd. share price is currently at 316.55, which is down by -8.20 from its previous closing. Today, the stock has fluctuated between 316.55 and 336.95. Over the past year, Shri Dinesh Mills Ltd. has achieved a return of -40.14 %. In the last month alone, the return has been 8.40 %. Read More...

Shri Dinesh Mills Ltd. Performance

Day Range

Low316.55 High336.95

324.75

52 Week Range

Low 262.00 High 572.80

324.75

Shri Dinesh Mills Ltd. Share Price

503804

SHRIDINE

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

336.95 Prev. Close

324.75 Volume (Shares)

2695.00

Total traded value

8.84 Upper Circuit

389.70 Lower Circuit

259.80

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Shri Dinesh Mills Ltd. Fundamentals

(Standalone)

Market Cap (Cr)	177.28
PE Ratio (TTM)	52.38
Book Value / Share	334.61
Beta	0.68

ROE	8.03%
EPS (TTM)	18.93
Dividend Yield	9.69%
Net Profit Qtr (Cr)	-0.82

Shri Dinesh Mills Ltd. Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	16.15
Operating Expense	15.67
Net Profit	-0.82
Net Profit Margin (%)	-5.07
Earnings Per Share (EPS)	-1.47
EBITDA	1.11
Effective Tax Rate (%)	783.33

Particulars	SEP 2024 (Values in Cr)
Revenue	14.71
Operating Expense	14.50
Net Profit	3.40
Net Profit Margin (%)	23.11
Earnings Per Share (EPS)	6.07
EBITDA	5.10
Effective Tax Rate (%)	17.47

Particulars	JUN 2024 (Values in Cr)
Revenue	14.78
Operating Expense	13.62
Net Profit	3.81
Net Profit Margin (%)	25.77
Earnings Per Share (EPS)	6.81
EBITDA	5.64
Effective Tax Rate (%)	20.79

Particulars	MAR 2024 (Values in Cr)
Revenue	18.53
Operating Expense	18.02
Net Profit	-3.08
Net Profit Margin (%)	-16.62
Earnings Per Share (EPS)	-5.51
EBITDA	-1.48
Effective Tax Rate (%)	-32.75

Particulars	DEC 2023 (Values in Cr)
Revenue	17.13
Operating Expense	14.00
Net Profit	39.70
Net Profit Margin (%)	231.75
Earnings Per Share (EPS)	70.89
EBITDA	49.70
Effective Tax Rate (%)	18.91

Particulars	MAR 2024 (Values in Cr)
Revenue	66.88
Operating Expense	58.41
Net Profit	47.90
Net Profit Margin (%)	71.62
Earnings Per Share (EPS)	85.53
EBITDA	64.47
Effective Tax Rate (%)	22.12

Particulars	MAR 2023 (Values in Cr)
Revenue	59.71
Operating Expense	56.32
Net Profit	22.95
Net Profit Margin (%)	38.43
Earnings Per Share (EPS)	40.97
EBITDA	31.70
Effective Tax Rate (%)	18.39

Particulars	MAR 2022 (Values in Cr)
Revenue	55.11
Operating Expense	49.98
Net Profit	26.51
Net Profit Margin (%)	48.10
Earnings Per Share (EPS)	47.33
EBITDA	33.97
Effective Tax Rate (%)	12.88

Particulars	MAR 2021 (Values in Cr)
Revenue	49.12
Operating Expense	43.96
Net Profit	8.81
Net Profit Margin (%)	17.93
Earnings Per Share (EPS)	16.05
EBITDA	14.24
Effective Tax Rate (%)	10.19

Particulars	MAR 2020 (Values in Cr)
Revenue	46.81
Operating Expense	49.61
Net Profit	1.74
Net Profit Margin (%)	3.71
Earnings Per Share (EPS)	3.30
EBITDA	10.27
Effective Tax Rate (%)	-13.17

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	359.72
ROE %	4.47
ROCE %	5.89
Total Debt to Total Equity	0.10
EBITDA Margin	17.42

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	280.53
ROE %	5.59
ROCE %	6.42
Total Debt to Total Equity	0.07
EBITDA Margin	16.80

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	245.76
ROE %	10.99
ROCE %	11.40
Total Debt to Total Equity	0.05
EBITDA Margin	22.97

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	197.41
ROE %	9.01
ROCE %	9.54
Total Debt to Total Equity	0.05
EBITDA Margin	22.64

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	181.24
ROE %	-3.54
ROCE %	-2.96
Total Debt to Total Equity	0.07
EBITDA Margin	5.76

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	351.74
ROE %	8.03
ROCE %	9.79
Total Debt to Total Equity	0.01
EBITDA Margin	31.58

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	277.37
ROE %	5.02
ROCE %	5.52
Total Debt to Total Equity	-0.01
EBITDA Margin	19.86

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	244.26
ROE %	6.35
ROCE %	6.75
Total Debt to Total Equity	-0.01
EBITDA Margin	22.10

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	202.13
ROE %	7.05
ROCE %	7.56
Total Debt to Total Equity	0.00
EBITDA Margin	25.73

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	188.13
ROE %	-2.40
ROCE %	-2.68
Total Debt to Total Equity	0.00
EBITDA Margin	5.51

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	4.85
Total Assets	270.85
Total Liabilities	270.85
Total Equity	209.02
Share Outstanding	5600582
Price to Book Ratio	1.36
Return on Assets (%)	18.66
Return on Capital (%)	21.68

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	3.63
Total Assets	219.56
Total Liabilities	219.56
Total Equity	168.59
Share Outstanding	5600582
Price to Book Ratio	1.86
Return on Assets (%)	10.86
Return on Capital (%)	13.06

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	5.07
Total Assets	186.44
Total Liabilities	186.44
Total Equity	148.96
Share Outstanding	5600582
Price to Book Ratio	3.01
Return on Assets (%)	16.10
Return on Capital (%)	19.2

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	2.37
Total Assets	146.90
Total Liabilities	146.90
Total Equity	119.15
Share Outstanding	5600582
Price to Book Ratio	1.75
Return on Assets (%)	6.68
Return on Capital (%)	7.89

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	1.93
Total Assets	136.65
Total Liabilities	136.65
Total Equity	104.93
Share Outstanding	5300582
Price to Book Ratio	0.48
Return on Assets (%)	0.80
Return on Capital (%)	1

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	1.33
Total Assets	231.11
Total Liabilities	231.11
Total Equity	196.99
Share Outstanding	5600582
Price to Book Ratio	1.36
Return on Assets (%)	20.72
Return on Capital (%)	23.67

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	2.90
Total Assets	183.10
Total Liabilities	183.10
Total Equity	155.34
Share Outstanding	5600582
Price to Book Ratio	1.86
Return on Assets (%)	12.53
Return on Capital (%)	14.87

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	4.71
Total Assets	158.56
Total Liabilities	158.56
Total Equity	136.80
Share Outstanding	5600582
Price to Book Ratio	3.01
Return on Assets (%)	16.71
Return on Capital (%)	19.49

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	2.00
Total Assets	130.54
Total Liabilities	130.54
Total Equity	113.20
Share Outstanding	5600582
Price to Book Ratio	1.75
Return on Assets (%)	6.74
Return on Capital (%)	7.83

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	1.53
Total Assets	121.34
Total Liabilities	121.34
Total Equity	100.84
Share Outstanding	5300582
Price to Book Ratio	0.48
Return on Assets (%)	1.43
Return on Capital (%)	1.73

Particulars	MAR 2024 (Values in Cr)
Net Income	60.23
Cash from Operations	2.84
Cash from Investing	2.04
Cash from Financing	2.73
Net change in Cash	1.05
Free Cash Flow	16.93

Particulars	MAR 2023 (Values in Cr)
Net Income	29.17
Cash from Operations	10.69
Cash from Investing	-10.62
Cash from Financing	0.96
Net change in Cash	-1.67
Free Cash Flow	21.74

Particulars	MAR 2022 (Values in Cr)
Net Income	36.60
Cash from Operations	13.06
Cash from Investing	-10.98
Cash from Financing	0.55
Net change in Cash	2.64
Free Cash Flow	23.02

Particulars	MAR 2021 (Values in Cr)
Net Income	11.67
Cash from Operations	10.20
Cash from Investing	-11.92
Cash from Financing	2.14
Net change in Cash	0.42
Free Cash Flow	11.27

Particulars	MAR 2020 (Values in Cr)
Net Income	0.13
Cash from Operations	2.87
Cash from Investing	-3.38
Cash from Financing	-1.98
Net change in Cash	-2.49
Free Cash Flow	5.08

Particulars	MAR 2024 (Values in Cr)
Net Income	61.51
Cash from Operations	-2.56
Cash from Investing	6.87
Cash from Financing	0.60
Net change in Cash	-1.65
Free Cash Flow	10.55

Particulars	MAR 2023 (Values in Cr)
Net Income	28.11
Cash from Operations	24.97
Cash from Investing	-19.47
Cash from Financing	-4.59
Net change in Cash	-1.82
Free Cash Flow	27.20

Particulars	MAR 2022 (Values in Cr)
Net Income	30.43
Cash from Operations	26.25
Cash from Investing	-22.25
Cash from Financing	-1.33
Net change in Cash	2.65
Free Cash Flow	31.28

Particulars	MAR 2021 (Values in Cr)
Net Income	9.81
Cash from Operations	9.17
Cash from Investing	-11.68
Cash from Financing	2.95
Net change in Cash	0.44
Free Cash Flow	9.62

Particulars	MAR 2020 (Values in Cr)
Net Income	1.12
Cash from Operations	2.15
Cash from Investing	-2.21
Cash from Financing	-2.69
Net change in Cash	-2.75
Free Cash Flow	3.16

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ARVIND LIMITED	333.10	28.94	2.48	8721.16	271.55 / 450.40
BLUE BLENDS (INDIA) LTD.	0.97	0.00	-0.04	2.10	0.00 / 0.00
BOMBAY DYEING & MFG. CO L	126.80	30.41	1.04	2618.86	117.25 / 256.25
CENTURY ENKA LTD	498.50	13.62	0.77	1089.22	416.00 / 863.90

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ARVIND LIMITED	333.10	37.05	2.55	8721.16	271.55 / 450.40
BLUE BLENDS (INDIA) LTD.	0.97	0.00	-0.04	2.10	0.00 / 0.00
BOMBAY DYEING & MFG. CO L	126.80	30.55	1.05	2618.86	117.25 / 256.25
CENTURY ENKA LTD	498.50	13.54	0.77	1089.22	416.00 / 863.90

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 297.60
26 Days 294.40
10 Days 292.90
50 Days 311.50
12 Days 292.00
100 Days 346.70
20 Days 292.00
200 Days 393.20

312.53
PIVOT

First Resistance	330.02
Second Resistance	350.48
Third Resistance	367.97

First Support	292.07
Second Support	274.58
Third Support	254.12

RSI	60.20
MACD	-2.43
Commodity Channel Index (CCI)	252.69

ADX	24.69
Williams % R	-33.03

Shri Dinesh Mills Ltd. Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

50.15 Promoter Holdings

49.78 FII

0.0 DII

0.06 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Bharat Upendra Patel	Shareholding of Promoter and Promoter Group	795088.0	14.2
Nimish Upendra Patel	Shareholding of Promoter and Promoter Group	768852.0	13.73
Nishank Nimishbhai Patel	Shareholding of Promoter and Promoter Group	504490.0	9.01
Aditya B Patel	Shareholding of Promoter and Promoter Group	492443.0	8.79
Jayesh Pratapchand Shah	Public Shareholding	134500.0	2.4
Gaurav N Lodha	Public Shareholding	104000.0	1.86
Kwality Alutrade Private Limited	Public Shareholding	98500.0	1.76
Iepf Authority	Public Shareholding	94530.0	1.69
Monica Subodh Shah	Public Shareholding	91000.0	1.62
Popatlal Punamchand Shah	Public Shareholding	83500.0	1.49
Arushaben Nimishbhai Patel	Shareholding of Promoter and Promoter Group	83085.0	1.48
Bhavna Amit Motla	Public Shareholding	63500.0	1.13
Pranav Kumarpal Parekh	Public Shareholding	58253.0	1.04
Vinodchandra Mansukhlal Parekh	Public Shareholding	57418.0	1.03
Jayesh Pratapchand Shah	Public Shareholding	56025.0	1.0
Roopaben Bharatbhai Patel	Shareholding of Promoter and Promoter Group	54554.0	0.97
Minal Shekhar Desai	Shareholding of Promoter and Promoter Group	34640.0	0.62
Ranak Kamlesh Laskari	Shareholding of Promoter and Promoter Group	34060.0	0.61
Jemika Karna Parikh	Shareholding of Promoter and Promoter Group	21160.0	0.38

Shri Dinesh Mills Ltd.

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2023-08-25	10.0	Final	2023-08-26	Equity shares	2022-08-11	7.5	Final	2022-08-13	Equity shares	2021-08-05	5.0	Final	2021-08-07	Equity shares	2020-02-18	3.0	Interim	2020-02-22	Equity shares	2019-09-05	1.8	Final	2019-09-07	Equity shares	2018-09-12	1.5	Final	2018-09-15	Equity shares	2017-09-14	1.5	Final	2017-09-16	Equity shares	2016-08-25	1.5	Final	2016-08-27	Equity shares	2015-08-27	1.8	Final	2015-08-29	Equity shares	2014-08-07	1.8	Final	2014-08-09	Equity shares	2013-07-11	1.8	Final	2013-07-13	Equity shares	2012-07-19	2.0	Final	2012-07-23	Equity shares	2011-07-12	2.0	Final	2011-07-14	Equity shares	2010-08-03	2.0	Final	2010-08-05	Equity shares	2010-08-03	1.0	Special	2010-08-05	Equity shares	2009-08-04	2.0	Final	2009-08-06	Equity shares	2008-08-12	20.0	Final	2008-08-14	Equity shares	2007-08-10	20.0	Final	2007-08-14	Equity shares	2005-08-16	0.0	Final	2005-08-18	Equity shares

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read